TIPE2 and gastric carcinoma: We identified gracillin as a TIPE2 inducer from Rhizoma Paridis and elucidated the potential mechanism by which gracillin alleviates gastric carcinoma via TIPE2-mediated inhibition of proliferation, induction of endogenous apoptosis, and suppression of migration (Figure 9).